PROTODIOSCIN

Global evidence snapshot

The resolved identity has matching regulatory evidence in 0 of 13 indexed market datasets: 0 country records and 0 EU Annex records. Every result and evidence gap is listed below.

0 markets with evidence

Markets checked

13

Markets with evidence

0

Evidence gaps

13

Resolved identifiers

1

Resolved substance identity

CAS:55056-80-9

Ingredient index records:

PROTODIOSCIN

Cosmetic functions: SKIN CONDITIONING

26-O-beta-D-Glycopyranosyl-22-hydroxyfurost-5-ene-3beta,26-diol-3-O-beta-diglucorhamnoside

Open full local profile

1 matched or reported name

PROTODIOSCIN

Regulatory evidence across markets

None of the 13 markets tracked here holds an imported rule under the name PROTODIOSCIN.

That is a statement about this inventory, not about the law: no imported rule is not evidence that a substance is permitted. A rule may exist under a different name, under a CAS or EC number this glossary entry does not carry, or in a dataset not yet imported.

Check the markets and their sources Search every market for this name

Chemical identity and properties

PubChem 2D chemical structure for CAS 55056-80-9

CAS 55056-80-9PubChem CID 441891

Protodioscin is a furostanol glycoside that consists of the trisaccharide alpha-L-Rha-(14)-[alpha-L-Rha-(12)]-beta-D-Glc attached to position 3 of 26-(beta-D-glucopyranosyloxy)-3beta,22-dihydroxyfurost-5-ene via a glycosidic linkage. Found in several plant species including yams, asparagus and funugreek. It has a role as an antineoplastic agent, an antilipemic drug, a neuroprotective agent, an anti-inflammatory agent, an apoptosis inducer and a plant metabolite. It is a beta-D-glucoside, a pentacyclic triterpenoid, a cyclic hemiketal, a steroid saponin and a trisaccharide derivative. It derives from a hydride of a furostan. — ChEBI

IUPAC name: (2S,3R,4R,5R,6S)-2-[(2R,3S,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[[(1S,2S,4S,6R,7S,8R,9S,12S,13R,16S)-6-hydroxy-7,9,13-trimethyl-6-[(3R)-3-methyl-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-en-16-yl]oxy]-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol

Molecular formula: C51H84O22
Molecular weight: 1049.2 g/mol
Exact mass: 1048.54542430 Da
XLogP3: -1.3
Topological polar surface area: 346.0 Å²
Hydrogen-bond donors: 13
Hydrogen-bond acceptors: 22
Covalent units: 1
Defined stereocentres: 31

Also known as

D0LC3PH24PCHEBI:8588(3beta,22R,25R)-26-(beta-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl alpha-L-rhamnopyranosyl-(1->2)-[alpha-L-rhamnopyranosyl-(1->4)]-beta-D-glucopyranoside(3beta,22R,25R)-26-(beta-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl alpha-L-rhamnopyranosyl-(1->2)-(alpha-L-rhamnopyranosyl-(1->4))-beta-D-glucopyranosideRefChem:46278Furostanol IProtodioscin?UNII-D0LC3PH24P

16 more reported names

PROTODIOSCINEFurostane base-2H + O-Hex, O-Hex-dHex-dHexproto-dioscinProtodioscin (Standard)PROTODIOSCIN [WHO-DD]HY-N0799REX-A3793Furost-5-ene-3,22,26-triol 3-chacotrioside-26-glucopyranosideHY-N0799CCG-270619CS-6050EBC-509148AS-75278P7057(3b, 25R)-26-(b-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl O-6-deoxy-a-L-mannopyranosyl-(1-2)-O-[6-deoxy-a-L-mannopyranosyl-(1- 4)]-b-D-glucopyranoside(3beta,22R,25R)-26-(beta-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl alpha-L-rhamnopyranosyl-(1->2)-[alpha

Open full PubChem record PubChem annotations 3D structure image

External database identifiers

ChEBI:CHEBI:8588
ChEMBL:CHEMBL4782480
PubMed:22738987
PubMed:22642742
PubMed:22579841
PubMed:22368416
PubMed:22367665
PubMed:22296876
PubMed:22066185
PubMed:22022002
PubMed:21886973
PubMed:21647317
PubMed:21535581
PubMed:21503618

Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.

Additional authoritative substance research

Each link searches that source for this identity. A link is a research route, not a claim that the source holds an exact record. What each source is, and its legal weight

Cosmetic Ingredient Review safety assessments FDA Global Substance Registration System ILO/WHO International Chemical Safety Cards Japan NITE-CHRIP NIOSH Pocket Guide to Chemical Hazards OECD eChemPortal US EPA CompTox CTX APIs

Take this record further

Screen in a formula Open standalone comparison

Official source and scope

Imported from Commission Implementing Decision (EU) 2025/1175 (dataset version EU 2025/1175). The glossary supplies common ingredient names for the ingredient list required by Article 19(1)(g); it is not an approval or safety list.

Open official Decision